- Home
- KALV vs TRNS Comparison
KALV vs TRNS Comparison
Compare KALV & TRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- TRNS
- Stock Information
- Founded
- KALV N/A
- TRNS 1964
- Country
- KALV United States
- TRNS United States
- Employees
- KALV N/A
- TRNS N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- TRNS Electrical Products
- Sector
- KALV Health Care
- TRNS Industrials
- Exchange
- KALV Nasdaq
- TRNS Nasdaq
- Market Cap
- KALV 642.3M
- TRNS 748.7M
- IPO Year
- KALV N/A
- TRNS N/A
- Fundamental
- Price
- KALV $11.49
- TRNS $86.02
- Analyst Decision
- KALV Strong Buy
- TRNS Buy
- Analyst Count
- KALV 8
- TRNS 4
- Target Price
- KALV $24.83
- TRNS $108.67
- AVG Volume (30 Days)
- KALV 1.1M
- TRNS 128.8K
- Earning Date
- KALV 07-10-2025
- TRNS 07-28-2025
- Dividend Yield
- KALV N/A
- TRNS N/A
- EPS Growth
- KALV N/A
- TRNS N/A
- EPS
- KALV N/A
- TRNS 1.57
- Revenue
- KALV N/A
- TRNS $278,421,000.00
- Revenue This Year
- KALV N/A
- TRNS $10.74
- Revenue Next Year
- KALV N/A
- TRNS $6.60
- P/E Ratio
- KALV N/A
- TRNS $54.84
- Revenue Growth
- KALV N/A
- TRNS 7.30
- 52 Week Low
- KALV $7.30
- TRNS $67.56
- 52 Week High
- KALV $15.50
- TRNS $147.12
- Technical
- Relative Strength Index (RSI)
- KALV 35.75
- TRNS 58.58
- Support Level
- KALV $11.10
- TRNS $82.16
- Resistance Level
- KALV $12.17
- TRNS $88.32
- Average True Range (ATR)
- KALV 0.86
- TRNS 3.02
- MACD
- KALV -0.21
- TRNS 0.76
- Stochastic Oscillator
- KALV 30.34
- TRNS 81.88
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About TRNS Transcat Inc.
Transcat Inc is involved in providing calibration and laboratory instrument services and distribution of test, measurement, and control instrumentation. Its product and services portfolio consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, etc. The firm has Service and Distribution operating segments. It derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Estech, FLIR, Fluke, Keysight, and Megger among others. It serves to pharmaceutical, industrial manufacturing, energy, and chemical process industries.